70518-2949 NDC - DOXEPIN HYDROCHLORIDE ()

Drug Information

  • Product NDC: 70518-2949
  • Proprietary Name: DOXEPIN HYDROCHLORIDE
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: REMEDYREPACK INC.
Product Type:
FDA Application Number: ANDA213063
Marketing Category: ANDA
Start Marketing Date:11/27/2020
End Marketing Date:1/31/2024

Package Information

No. Package Code Package Description Billing Unit
170518-2949-030 CAPSULE in 1 BLISTER PACK (70518-2949-0)
270518-2949-1100 POUCH in 1 BOX (70518-2949-1) / 1 CAPSULE in 1 POUCH (70518-2949-2)

NDC Record

Field Name Field Value Definition
PRODUCT NDC70518-2949The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEDOXEPIN HYDROCHLORIDEIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
START MARKETING DATE11/27/2020The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
END MARKETING DATE1/31/2024The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
MARKETING CATEGORY NAMEANDAThe translation of the dosage form Code submitted by the firm.
APPLICATION NUMBERANDA213063The translation of the route code submitted by the firm, indicating route of administration.
LABELER NAMEREMEDYREPACK INC.This is the date that the labeler indicates was the start of its marketing of the drug product.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025